Gynecologic Malignancies

Gita Suneja, Akila Viswanathan

Research output: Contribution to journalReview article

Abstract

Gynecologic malignancies are among the most prevalent cancers affecting women worldwide, but they are heterogeneous diseases with varying risk factors, management paradigms, and outcomes. Gynecologic cancers mediated by human papillomavirus (HPV) are preventable and curable with early detection and treatment. Dramatic reductions in cervical cancer incidence and mortality have been achieved through cancer screening and HPV vaccination. Radiotherapy plays a central role in the management of gynecologic malignancies. For some cancers, radiotherapy alone can be curative. More often, radiotherapy is used in conjunction with surgery and systemic therapy to improve locoregional control and extend overall survival. This chapter reviews recent advances in radiotherapeutic management of gynecologic malignancies.

Original languageEnglish (US)
Pages (from-to)71-89
Number of pages19
JournalHematology/Oncology Clinics of North America
Volume34
Issue number1
DOIs
StatePublished - Feb 2020

    Fingerprint

Keywords

  • Brachytherapy
  • Cervical cancer
  • Image guidance
  • Intensity modulated radiotherapy
  • Uterine cancer
  • Vulvar cancer

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this